No Data
No Data
StemRIM Inc. Details New Stock Option Issuance
StemRIM Secures China Patent for Redasemtide Peptides
Stem Inc, MDNT and others [Emerging Markets Press Release]
Acquired and subordinated the stock of Swaying Wind, who operates the WOLVES animal hospital. Started manufacturing specific cell products ('S-DSC') for hair regeneration under contract with MDNT. Registered patents (China) for peptides related to the peripheral peptides of LedaSemchidot (HMGB1 fragment peptide) at Stemlim Regenerative Induction Medicine. Massive exercise of Fanpep's 11th subscription rights (with modification clause for exercise price) to issue 0.67 million 4,000 shares starting from the first day.
StemRIM Inc. Strengthens Patent Portfolio in China
StemRIM Inc. Finalizes Employee Stock Options
StemRIM Inc. Grants Stock Options to Directors
No Data